Other Clinical Trial - Correlation of Motor Metrics & Neurological Data

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT06283043` - Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
	Completed	`NCT01547481` - MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.

See also

Status

Clinical Trial

Phase

Enrolling by invitation

NCT06283043 - Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease

Completed

NCT01547481 - MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05462080
Study type	Observational
Source	Ceraxis Health, Inc
Contact	Stuart Holtham
Phone	2164455637
Email	houlths@ccf.org
Status	Recruiting
Phase
Start date	November 10, 2022
Completion date	April 1, 2023

Correlation of Motor Metrics and Neurological Data — COMMAND

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms